baber/WOPTO huggingface dataset:
Patent NZ-331533-A (NZ)
Title: Pharmaceutical combination preparation comprising an inhibitor of the sodium/hydrogen exchanger and a substance having cardiovascular activity
Inventor: SCHOLZ WOLFGANG
IPC: C07C317/44
Filed: 1998-08-25
Abstract: A synergistic pharmaceutical combination comprising an inhibitor of Na+/H- exchanger and a substance having cardiovascular activity is claimed. The substance having cardiovascular activity can be a guanidine, benzoyl guanidine, substituted by a sulphono or sulphonamide group, isoquinoline, benzothiazole, benzofuran, benzoxazole, benzothiophene, indole, benzimidazole, diacyl guanidine, isoquinoline guanidine, benzothiazine guanidine, perfluoroalkyl substituted phenylalkyl carboxylic acid guanidide, furan guanidine, thiophene guanidine, pyrrole guanidine, bicyclic heteroaroyl guanidine, perfuoroalkyl substituted phenylalkenyl carboxylic acid guanidide, indenoyl guanidine, benzyloxycarbonyl guanidine, fluoro substituted alkenylcarboxylic acid guanidide, cinnamic acid guanidide, sulphonimidamide substituted benzoyl guanidine, benzenedicarboxylic acid diguanidide, biphenyldicarboxlic acid diguanidide, thiophenylalkenylcarboxylic acid guanidide, 2-naphthoyl guanidine, indanylidineacetyl guanidine, phenylalkenylcarboxylic acid guanidine, indoloyl guanidine, benzofuran guanidine, benzothiophene guanidine or indolyl guanidine.
Patent NZ-334444-A (NZ)
Title: Carton comprising a flap extending from the edge of a first panel and an opening extending across a fold line in the first panel
Inventor: SCHOENWALD SANDRA
IPC: B65D71/12
Filed: 1997-08-21
Abstract: A carton formed from a blank 10 comprises a locking arrangement 22, 23, for first and second panels 16, 17, respectively.  A flap 27 projects from the end edge of panel 16 and an opening 29 is formed in panel 16.  Opening engaging means are provided on flap 27 and are constituted by oppositely disposed, laterally extending barbs 35 which engage behind cuts 31 which extend laterally from opening 29.  Flap 27 is hingedly connected to the remainder of panel 16 along a fold line 28.  Opening 29 divides fold line 28 into two parts and extends part way into the flap.  In use flap 27 is passed through a cooperating aperture 24 in panel 17 in an outwardly direction relative to the carton, is folded back over the portion of panel 17 between aperture 24 and the free edge 26 of panel 17 and is inserted into opening 29 in panel 16.
Patent NZ-507129-A (NZ)
Title: Method and system for monitoring animal movement in relation to position over time, health condition and proximity to diseased animals
Inventor: GUICHON P TIMOTHY
IPC: G08C21/00
Filed: 1998-03-24
Abstract: A method for tracking the movement of animals as they are moved from location to location that comprises: Tagging each animal under observation; tracking the location of each tagged animal and the duration each tagged animal spends at each location as it is moved and therefore generating data representing each tagged animal's movement history; and using the generated data to detect tagged animals that have been in physical proximity with a tagged animal diagnosed with a transmittable disease.
Patent NZ-507289-A (NZ)
Title: Planar capacitive coil on plug signal detection for combustion engine diagnosis
Inventor: FONG CHEE K
IPC: F02P3/02
Filed: 2000-10-02
Abstract: An apparatus for detecting electric ignition signals from a coil on plug of an internal combustion engine, the apparatus comprising a first conductive pickup planar layer a second conductive planar ground layer separated by and affixed to a non-conductive substrate and adapted for placement of the second conductive planar ground layer in close proximity to a coil of the coil on plug with the second conductive planar ground layer disposed between the first conductive pickup planar layer and the coil of the coil on plug.
Patent NZ-508923-A (NZ)
Title: N-phenyl-1-Methyl-2-oxo-quinoline-3-carboxamide derivatives, pharmaceuticals thereof and their use in therapy
Inventor: JONSSON STIG
IPC: A61P25/00
Filed: 1999-07-14
Abstract: Compounds of formula (I), wherein: R is Me, Et, n-Pr, iso-Pr, n-Bu, or allyl; R' is Me, MeO, fluoro, chloro, bromo, CF3, or OCHXFy; R" is hydrogen, fluoro or chloro, with the proviso that R" is fluoro or chloro only when R' is fluoro or chloro; R4 is hydrogen or a pharmaceutically acceptable inorganic or organic cation; R5 is Et, n-Pr, iso-Pr, MeO, EtO, chloro, bromo, trifluoromethyl, OCHXFy, OCH2CHXFy; x is 0 - 2, y is 1 - 3,  with the proviso that x + y = 3; R6 is H; or R5 and R6 taken together are methylenedioxy. Also described are pharmaceutical compositions containing as active ingredient a compound having the general formula (I) together with a pharmaceutically acceptable carrier.
Patent NZ-517412-A (NZ)
Title: Vehicle stabilizing system having pivotal support
Inventor: KAMEN DEAN L
IPC: A61G5/04
Filed: 2000-08-29
Abstract: A balancing vehicle that supports a rider on a support such as a seat in such a manner as to allow the position of the center of gravity of the vehicle to be varied by the motion of the support.  Motion of the support additionally provides for control of a drive that propels the vehicle in a manner responsive to the position of the center of gravity.  The vehicle is thus capable of control by leaning of a seated rider.
Patent NZ-518925-A (NZ)
Title: Crystalline form of (S)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid
Inventor: BOIJE MARIA
IPC: A61P3/06
Filed: 2000-11-29
Abstract: A crystalline form of the compound (S)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}-ethoxy)phenyl] propanoic acid shown in formula I. It is characterised by having a X-ray powder diffraction pattern containing specific peaks of high relative intensity at 6.2, 4.47 and 4.15 angstrom. The compound described by formula I may be used in the treatment or prophylaxis of conditions associated with a person with reduced sensitivity to insulin, metabolic disorders such as dyslipidaemia, type II diabetes, hyperglycermia, hyperinsulinaemia, arterial hypertension and or abdominal obesity.
Patent NZ-522242-A (NZ)
Title: Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
Inventor: BUCHANAN MICHAEL R
IPC: A61K47/44
Filed: 2001-04-06
Abstract: The use of an effective amount of an omega-3 fatty acids formulation comprising 13-HODE, in the manufacture of a medicament, to reduce the inhibition of endogenous 13-HODE synthesis which may occur when omega-3 fatty acids are orally administered to a subject.
Patent NZ-523291-A (NZ)
Title: Anti-alpha beta recombinant human antibodies, nucleic acids encoding same and methods for use
Inventor: HUSE WILLIAM D
IPC: A61P21/00
Filed: 2000-06-23
Abstract: The use of an enhanced LM609 grafted antibody exhibiting selective binding affinity to alpha vbeta 3, or a functional fragment thereof, comprising a CDR selected from the group consisting of a VH CDR2 referenced as SEQ ID NO:104; a VH CDR referenced as SEQ ID NO:106; and a VL CDR1 referenced as SEQ ID NO:110; in the manufacture of a medicament for the treatment of alpha vbeta 3 mediated diseases. Wherein the diseases maybe, diabetic retinopathy, neovascular glaucoma, macular degeneration, atherosclerosis, restenosis and osteoporosis.
Patent NZ-523494-A (NZ)
Title: A tray moving apparatus used in movable sporting activity surfaces
Inventor: EVERETT ROBERT
IPC: A63C19/00
Filed: 2002-12-24
Abstract: A tray moving apparatus (150) for constructing part of a reconfigurable activity surface, the apparatus (150) comprising a set of guide rails (160) and at least one tray (158) providing a first part of the activity surface which is movable on the rails (160), wherein the apparatus (150) is arranged to guide movement of the at least one tray (158) from a remote position (162) not engaging a second part of the activity surface to a local position (164) for accurately engaging the second part of the activity surface, the apparatus (150) further comprising means provided at least in part at the local position (164) for moving the at least one tray (158) laterally with respect to the direction of travel of the tray (158) on the rails (160) in order to effect engagement alignment of the tray (158) with an edge of the second part of the activity surface.
Patent NZ-527697-A (NZ)
Title: Display apparatus
Inventor: GIBBS GRAHAM RODIER
IPC: G09F19/00
Filed: 2003-08-18
Abstract: A display apparatus comprising: an indicia carrying substrate support means (81) and a backing means (83), the indicia carrying substrate support means including: a) a quadrilateral shaped frame of top, sides and bottom perimeter members to define a border about the indicia carrying substrate to be carried by the indicia carrying substrate support means, the frame presenting a clamping rim (10) (continuous or not) parallel to the plane of the frame; b) at least one substantially rigid clamping sheet (9), biased by at least one biasing means (8) of the indicia carrying substrate support means towards the clamping rim yet allowing the clamping sheet to be pressed away from at least part of the clamping rim in a direction opposite to the direction of bias, wherein part of the indicia carrying substrate can be selectively captured between the clamping sheet and the clamping rim to become retained with the display apparatus. The indicia carrying substrate support means is hinged with the backing means to be rotatable relative to the backing means and movable between a first position and a second position. The backing means includes a means to hold (80) which when the indicia carrying substrate support means and the backing means are in the first position, hold the clamping sheet relative to the clamping rim to thereby prevent the movement of the clamping sheet in the direction opposite to the direction of bias, and when the indicia carrying substrate support means and the backing means are in the second position, being a position where the indicia carrying substrate support means and backing means are rotated away from each other, the means to hold is released from holding the clamping sheet.
Patent NZ-530001-A (NZ)
Title: Remedies for eosinophilic diseases via CD30-mediated signalling
Inventor: MIURA KENJU
IPC: A61P11/00
Filed: 2002-06-21
Abstract: The use of Ber-H8 or HRS-4 to induce eosinophil apoptosis via CD30 and/or a molecule involved in CD30 signal transduction in the production of a medicament for treating hypereosinophilic disease. If HRS-4 is used then the hypereosinophilic disease is not Hodgkin's disease.
Patent NZ-531939-A (NZ)
Title: Controllable moving fence for controlling the movement of a livestock on a feeding pasture lot
Inventor: MACERI FRANCISCO J
IPC: A01K3/00
Filed: 2004-03-25
Abstract: Described is a controllable fence system for handling livestock and for controlling the consuming of pasture during the feeding of livestock, comprising a boundary fence with opposite sides defining a lot, each of the opposite sides having at least one side wire; and at least one controllable moving fence, which comprises, two opposite ends with each end connected to one corresponding side of the opposite sides of the boundary fence and capable of moving along the corresponding opposite side of the boundary fence; and a moving carrier comprising a support base of electrical insulating material connected to driving means connected to each end of the moving fence for moving the carrier along the at least one side wire of each of the opposite sides of the boundary fence, the carrier including driving wheels and guiding-contacting wheels for moving and guiding along the at least one side wire of the opposite sides of the boundary fence, the guiding-contacting wheels being resiliently mounted in the carrier for resiliently contacting the respective at least one side wire of the fence sides. The electronic control and electrification unit comprise a second-minute-hour-day programmable timer for operating the carriers according to a programmed motion pattern and a computer with a program stored therein, the program processing clock data, operation periods data, number of animals, sizes of animals and pasture density.
Patent NZ-534540-A (NZ)
Title: Described is the development of a stem cell bank for teeth or teeth derived tissues, as well as the development of membrane-like meso/endodermal matrices which can be used in regenerative medicine
Inventor: SCHIERHOLZ JORG
IPC: A61K35/12
Filed: 2003-02-05
Abstract: A stem cell obtained from the non-embryonic tissue isolated from the dental follicle of a tooth or wisdom tooth that is able to differentiate into a periodontal ligament-like membrane structure is described.
Patent NZ-535590-A (NZ)
Title: Promotion or inhibition of angiogenesis and cardiovascularization
Inventor: ASHKENAZI AVI
Filed: 1999-11-30
Abstract: A composition comprises a polypeptide which has at least 80% sequence identity to an SEQ ID No: 203 or an antibody which specifically binds to the polypeptide. The polypeptide is useful for the promotion or inhibition of angiogenesis and cardiovascularization.
Patent NZ-535631-A (NZ)
Title: Impact resistant assembly with foam masses located in perforations of impact resistant sheet and contacting at least one flexible sheet
Inventor: RADAICH ANTON
Filed: 2004-09-27
Abstract: Foam masses are located in respective perforations of an impact resistant sheet. At least one flexible sheet is in contact with the foam masses and typically two such flexible sheets are adhered to the impact resistant sheet.
Patent NZ-542355-A (NZ)
Title: Multilayer barrier structures, methods of making the same and packages made therefrom
Inventor: DOUGLAS MICHAEL J
IPC: B65D81/34
Filed: 2004-03-05
Abstract: Multilayer structures, methods of making the same and packages made therefrom are provided. The multilayer structures are useful for packaging bone-in meat or other like products. More specifically, the multilayer structures have sufficient rigidity and strength to contain bone-in meat or other like products, while also maintaining good oxygen barrier properties. In addition, multilayer structures can easily seal to themselves or to other structures. Moreover, the multilayer structures are biaxially oriented and heat-shrinkable.
Patent NZ-544247-A (NZ)
Title: Phototherapy using psoralen derivatives and a UVB absorber
Inventor: DECOLA DENNIS
Filed: 2005-12-19
Abstract: Oil-in-water emulsion compositions containing a photoactivable agent and an agent that absorbs or blocks extraneous radiation (such as UVA or UVB) during phototherapy are disclosed. The photoactivable compound may be a psoralen or psoralen derivative selected from 8-methoxy-psoralen; 4,5',8-trimethylpsoralen; 4-methylpsoralen; 4,4-dimethylpsoralen; 4-5'-dimethylpsoralen; 4'-aminomethyl-4,5',8-trimethylpsoralen; 4'-hydroxymethyl-4,5',8-trimethylpsoralen; and 4',8-methoxy psoralen. The agent that absorbs or blocks extraneous radiation may be a UVA absorbing agent selected from dibenzoylmethane derivatives and anthranilate derivatives. The agent that absorbs or blocks extraneous radiation may be a UVB absorbing agent selected from 3-benzylidenecamphor derivatives, 4-aminobenzoic acid derivatives, esters of cinnamic acid, esters of salicylic acid, derivatives of benzophenone, esters of benzalmalonic acid, 2,4,6-trianilino-(p-carbo-2'-ethyl-1'-hexyloxy)-1,3,5-triazine, salts of 2-phenylbenzimidazole-5-sulphonic acid, sulphonic acid derivatives of benzophenones and sulphonic acid derivatives of 3-benzylidenecamphor. These compositions are suitable for use in the treatment of leukocyte mediated autoimmune diseases such as psoriasis, CTCL, and vitiligo.
Patent NZ-548162-A (NZ)
Title: Food and feed supplement and its use
Inventor: BRAKSTAD FRODE
IPC: A23K1/18
Filed: 2004-12-06
Abstract: Disclosed is a food and feed supplement, and its use, where the supplement comprise as the basic component at least one carboxylic acid and/or its salt, an iron component and vitamins B6, B9 and B12 in amounts corresponding to at least that which theoretically can be consumed during the metabolism of the COOH-groups present. The supplement may also contain a desiccant and an antioxidant. The supplement will have a pH in the range 2.0-6.0 when dissolved in water. The supplement is characterized in that the amounts of the vitamins B6, B9 and B12 are in the range of 0,5-30mg, 0,1-10mg and 1-1500 [mu]g/gram dry weight of the content of the pure carboxylic acids in the supplement, respectively. The supplement can be used in animal feed in amounts of 0.5-15 grams dry supplement/kg dry feed.
Patent NZ-550229-A (NZ)
Title: Proline derivatives and their use as dipeptidyl peptidase IV inhibitors
Inventor: HULIN BERNARD
IPC: C07D207/14
Filed: 2005-04-29
Abstract: Disclosed is a compound of formula (I), or a pharmaceutically acceptable salt, or solvent thereof, wherein Q is a bond, -C(O)-, or SO2-, HET is an optionally substituted heterocyclic ring, n is 0 or 1, and wherein the other subtituents are as disclosed in the specification. Also disclosed is the use of the compound for treating a condition mediated by dipeptidyl peptidase-IV, such as Type 2 diabetes, Type 1 diabetes, impaired glucose tolerance, hyperglycemia, metabolic syndrome (syndrome X and/or insulin resistance syndrome), glucosuria, metabolic acidosis, arthritis, cataracts, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic cardiomyopathy, obesity, conditions exacerbated by obesity, hypertension, hyperlipidemia, atherosclerosis, osteoporosis, osteopenia, frailty, bone loss, bone fracture, acute coronary syndrome, short stature due to growth hormone deficiency, infertility due to polycystic ovary syndrome, anxiety, depression, insomnia, chronic fatigue, epilepsy, eating disorders, chronic pain, alcohol addiction, diseases associated with intestinal motility, ulcers, irritable bowel syndrome, inflammatory bowel syndrome; short bowel syndrome; and the prevention of disease progression in Type 2 diabetes.
Patent NZ-554324-A (NZ)
Title: Hybrid ventilator which can be driven either by a motor or by wind
Inventor: MUNN DEREK LAWRENCE ALAN
IPC: F24F7/007
Filed: 2005-09-23
Abstract: A ventilator 10 comprises a ventilator stator 12 for mounting to a structure, a ventilator rotor 14 for mounting and rotation with respect to the ventilator stator 12, and a motor 20 comprising a motor rotor and a motor stator for operation between the ventilator rotor 14 and ventilator stator 12. The rotor 14 comprises one or more winddrivable elements 44, and is mounted to extend from the stator 12 in use so that the one or more wind drivable elements 44 are not surrounded by the stator 12 but are substantially exposed to the wind in use. The rotor 14 is able to be wind driven, motor driven or both. The motor 20 is arranged to permit selection of wind driven and/or motor driven rotation of the ventilator rotor 14. The motor 20 connects the ventilator rotor 14 to the ventilator stator 12, such that the motor rotor is connected to the ventilator rotor 14 and the motor stator is connected to the ventilator stator 14, and is located on an axis of the rotor 14.
Patent NZ-554932-A (NZ)
Title: Compacting machine with a compaction chamber with at least one rotating plate
Inventor: ROTA GUIDO
IPC: A01F15/07
Filed: 2005-01-14
Abstract: A compacting machine 20 comprising a compaction chamber connected to introduction means 11 arranged to forcedly introduce a predetermined quantity of material to be compacted into the compaction chamber by conferring on the material a substantially rotary movement, wherein - the compaction chamber is substantially cylindrical and comprises circular plates 2 positioned at the ends of the compaction chamber and acting as end walls of the compaction chamber, the circular plates 2 being made to rotate about an axis perpendicular to the circular plates 2 and being arranged to at least partly close the compaction chamber laterally, the compaction chamber having a lateral surface defined and bounded by longitudinally disposed perimetral rollers 3 each rotatable about its axis, wherein engagement grooves are provided at the ends of the perimetral rollers 3 in correspondence with the end walls of the compaction chamber and wherein the circular plates 2 have an edge engaged in the engagement grooves of the perimetral rollers 3.
Patent NZ-555085-A (NZ)
Title: Liquid infusing and flavouring device, typically for beer, operable between non infusing-flavouring and infusing-flavouring modes
Inventor: LITTLE CHRISTOPHER JOHN
Filed: 2007-05-09
Abstract: The liquid infusing and flavouring device 1 is shown installed upstream of a beer dispensing tap 7. By movement of handle 32 either a non infusing-flavouring mode is provided whereby beer by-passes container 2, or an infusing-flavouring mode is provided whereby beer flows through container 2 to be infused and flavoured.
Patent NZ-564015-A (NZ)
Title: Bag with leak resistant features
Inventor: BROERING SHAUN T
IPC: B64F1/02
Filed: 2006-05-31
Abstract: A leak resistant bag is disclosed. The bag comprises a first pliable sidewall, a second pliable sidewall, and an absorbent-adhesive mixture. The second pliable sidewall overlies and joins to the first sidewall along a closed bottom edge to provide an interior volume. The interior volume accessible via an opening disposed between the first and second sidewalls. The absorbent-adhesive mixture comprises an absorbent agent and an adhesive. The absorbent-adhesive mixture is located on both the first and second sidewalls along the closed bottom edge.
Patent NZ-568386-A (NZ)
Title: Production of conjugates using a thiol generator
Inventor: GEE NICHOLAS STEVEN
IPC: A61K47/48
Filed: 2006-12-12
Abstract: Disclosed is a method of reacting a first chemical entity which is a biomolecular polymer, and a second chemical entity, to form a conjugate in which the first and second chemical entities are covalently bound with respect to each other, comprising bringing into simultaneous contact, in aqueous conditions, the first chemical entity, the second chemical entity and a thiol generator, wherein the thiol generator reacts with the first chemical entity in a thiolation reaction resulting in formation of a free sulfhydryl group on the first chemical entity, and the free sulfhydryl group reacts with the second chemical entity to form the conjugate, and wherein the second chemical entity is polyvalent with respect to its reactivity with sulfhydryl groups and further wherein the molar ratio of second chemical entity to thiol generator is less than 1:1. The disclosure also relates to a conjugation kit for use in said method, wherein the kit comprises: a plurality of aliquots of 2-iminothiolane buffered to below pH 6.5 in dried form; a plurality of aliquots of a second chemical entity, in dried form, either separate or in admixture with the aliquots of 2-iminothiolane; and instructions for performing the method.
Patent NZ-569507-A (NZ)
Title: Viral hepatitis treatment using nitazoxanide or tizoxanide
Inventor: ROSSIGNOL JEAN-FRANCOIS
IPC: A61K31/425
Filed: 2007-01-09
Abstract: Disclosed herein is the use of a compound selected from nitazoxanide, tizoxanide, or mixtures thereof, and a pharmaceutically acceptable carrier, in the manufacture of a medicament for inducing a virologic response that is sustained for at least 24 weeks in a patient suffering from a hepatitis C virus (HCV) infection. Also disclosed is a composition comprising a) one or more compounds selected from nitazoxanide, tizoxanide or mixtures thereof; b) an interferon; and c) an anti-diabetes agents, for use in inducing a virologic response that is sustained for at least 24 weeks in a subject suffering from a hepatitis C virus (HCV) infection.